NCT03206671 Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03202628 Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT03200600 Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery Status TERMINATED Phase PHASE4
NCT03193788 Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Status UNKNOWN Phase PHASE3
NCT03183596 Optimal Injection Site for Serratus Anterior Plane Block in Reconstructive Breast Surgery Status WITHDRAWN Phase PHASE3
NCT03180736 Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex Status COMPLETED Phase PHASE3
NCT03177317 Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy Status COMPLETED Phase NA
NCT03173092 A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) Status TERMINATED Phase PHASE4
NCT03172988 Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery Status TERMINATED Phase PHASE4
NCT03171974 Ultrasound Guided Treatment of Steroids for Capsular Contracture in Patients With Reconstructed/Augmented Breast Status UNKNOWN Phase NA
NCT03170882 A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT03168100 2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT03166761 Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection Status TERMINATED Phase PHASE4
NCT03161938 High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase Status COMPLETED Phase PHASE4
NCT03160729 High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Nephrectomy Status TERMINATED Phase PHASE4
NCT03158688 Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. Status COMPLETED Phase PHASE3
NCT03155100 Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines Status COMPLETED Phase PHASE2
NCT03151811 A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide Status TERMINATED Phase PHASE3
NCT03150693 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE3